276 related articles for article (PubMed ID: 16617066)
1. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
3. The mode of action and the mechanism of resistance to antimalarial drugs.
Foote SJ; Cowman AF
Acta Trop; 1994 Mar; 56(2-3):157-71. PubMed ID: 8203302
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
5. Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?
Platteeuw JJ
Trop Med Int Health; 2006 Jun; 11(6):804-8. PubMed ID: 16772001
[TBL] [Abstract][Full Text] [Related]
6. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
Tuteja R
FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in antimalarial compounds and their patents.
Mital A
Curr Med Chem; 2007; 14(7):759-73. PubMed ID: 17346161
[TBL] [Abstract][Full Text] [Related]
8. [Current antimalarial drugs: resistance and new strategies].
Ringwald P
Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
[TBL] [Abstract][Full Text] [Related]
9. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.
Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
Trends Parasitol; 2005 Jun; 21(6):292-8. PubMed ID: 15922251
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance in falciparum malaria.
May J; Meyer CG
Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
[No Abstract] [Full Text] [Related]
11. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
12. [Role of modulators in Plasmodium falciparum resistance to antimalarials].
Verdier F; Pussard E
Med Trop (Mars); 1995; 55(4 Suppl):27-32. PubMed ID: 8649262
[TBL] [Abstract][Full Text] [Related]
13. [Is the in vivo test for resistance to antimalarial agents in malaria as defined by the WHO valid?].
Cabezos J; Bada JL; Asmarats L
Med Clin (Barc); 1992 Oct; 99(11):436. PubMed ID: 1469944
[No Abstract] [Full Text] [Related]
14. The phenothiazinium chromophore and the evolution of antimalarial drugs.
Wainwright M; Amaral L
Trop Med Int Health; 2005 Jun; 10(6):501-11. PubMed ID: 15941412
[TBL] [Abstract][Full Text] [Related]
15. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
16. The activity of PS-15 in combination with sulfamethoxazole.
Yeo AE; Rieckmann KH
Trop Med Parasitol; 1994 Jun; 45(2):136-7. PubMed ID: 7939165
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial drug therapy: the role of parasite biology and drug resistance.
Daily JP
J Clin Pharmacol; 2006 Dec; 46(12):1487-97. PubMed ID: 17101748
[TBL] [Abstract][Full Text] [Related]
18. The global portfolio of new antimalarial medicines under development.
Olliaro P; Wells TN
Clin Pharmacol Ther; 2009 Jun; 85(6):584-95. PubMed ID: 19404247
[TBL] [Abstract][Full Text] [Related]
19. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
[TBL] [Abstract][Full Text] [Related]
20. Strategies to reverse drug resistance in malaria.
Egan TJ; Kaschula CH
Curr Opin Infect Dis; 2007 Dec; 20(6):598-604. PubMed ID: 17975410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
